Ovoca Resources PLC
11 May 2005
Ovoca Resources plc ("Ovoca or the "Company")
Director appointments and
Award of options to directors
Director appointments
On 10 May 2005, Mr. Roger Turner and Dr. Barrie Oakes were co-opted to the board
of the Company following completion of the acquisition of a 78 percent interest
in the issued share capital of Norplat Limited ("Norplat").
Mr. Turner has not held at any time in the previous five years and does not
currently hold any directorships in public limited companies save as listed
below.
Current Previous
Minco plc Oxus Gold plc
Angus & Ross plc
There are no details specified by schedule 2 paragraph (f) of the IEX Rules to
be disclosed in relation to Mr. Turner. Mr. Turner's shareholding (including
interests of connected parties) is 2,864,438 ordinary shares of €0.025 each,
representing 3.1% of the total issued share capital of the Company as enlarged
following the acquisition of Norplat. On 10 May 2005 Mr. Turner was awarded
options over 425,000 ordinary shares in the share capital of the Company which
are exercisable at €0.11 up to May 2015.
Dr. Oakes has not held at any time in the previous five years and does not
currently hold any directorships in any other company and there are no details
specified by schedule 2 paragraph (f) of the IEX Rules to be disclosed in
relation to Dr. Oakes. Dr. Oakes' shareholding (including interests of
connected parties) is 3,719,889 ordinary shares of €0.025 each, representing 4%
of the total issued share capital of the Company as enlarged following the
acquisition of Norplat. On 10 May 2005 Dr. Oakes was awarded options over
425,000 ordinary shares in the share capital of the Company which are
exercisable at €0.11 up to May 2015.
Mr. Turner and Dr. Oakes have entered into an undertaking with the Company that
they will not sell or dispose of, or agree to sell or dispose of, any of their
shareholding in Ovoca for 12 months following the date of admission of their
ordinary shares to trading on the IEX (which is expected to occur by 16 May
2005).
Grant of options to directors
In addition to the grant of options described above, on 10 May 2005 Mr. Richard
O Shea, Mr. John O Connor and Mr. Harry Dobson were each granted options over
250,000 ordinary shares in the share capital of the Company which are
exercisable at €0.11 up to May 2015 and Mr. Paul Smithwick was granted options
over 100,000 ordinary shares in the share capital of the Company which are
exercisable at €0.11 up to May 2015.
As at 11 May 2005 the directors of the Company hold the following options over
ordinary shares in the capital of the Company:
Director Total Options held at 11 May 2005
Roger Turner 425,000
Barrie Oakes 425,000
Richard O Shea 975,000
John O Connor 990,000
Harry Dobson 1,175,000
Paul Smithwick 990,000
Contact:
John O'Connor +353 (0)1 491 2950
This announcement has been issued through the Companies Announcement Service of
the Irish Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.